SKI Market

Indian Indices

Sensex

82,566.37 221.69
( 0.27%)

Global Indices

Nasdaq

49,020.90 -412.51
(-0.83%)

Dow Jones

6,999.25 28.02
(0.40%)

Hang Seng

53,521.14 162.43
(0.30%)

Nikkei 225

10,179.25 24.82
(0.24%)

Forex

USD-INR

91.63 -0.01
(-0.02%)

EUR-INR

109.29 0.55
(0.50%)

GBP-INR

125.84 0.55
(0.44%)

JPY-INR

0.60 0.00
(0.30%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

81.59

381326.31

EPS(TTM)

Face Value()

Div & Yield %

19.48

1.01

Back

alka india ltd

Nyssa Corporation reports consolidated net loss of Rs 0.02 crore in the September 2025 quarter

Nov 17,2025

Net loss of Nyssa Corporation reported to Rs 0.02 crore in the quarter ended September 2025 as against net profit of Rs 0.97 crore during the previous quarter ended September 2024. Sales declined 90.00% to Rs 0.14 crore in the quarter ended September 2025 as against Rs 1.40 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	0.14	1.40	-90
OPM %	-78.57	83.57	-
PBDT	-0.02	1.32	PL
PBT	-0.02	1.32	PL
NP	-0.02	0.97	PL

82,566.37 221.69 ( 0.27%)

49,020.90 -412.51 (-0.83%)

6,999.25 28.02 (0.40%)

53,521.14 162.43 (0.30%)

10,179.25 24.82 (0.24%)

91.63 -0.01 (-0.02%)

109.29 0.55 (0.50%)

125.84 0.55 (0.44%)

0.60 0.00 (0.30%)